<bill session="115" type="h" number="5686" updated="2019-04-18T16:23:05Z">
  <state datetime="2018-05-09">REPORTED</state>
  <status>
    <unknown datetime="2018-05-09"/>
  </status>
  <introduced datetime="2018-05-07"/>
  <titles>
    <title type="official" as="introduced">To amend title XVIII of the Social Security Act to require prescription drug plans under Medicare part D to include information on the adverse effects of opioid overutilization and of coverage of nonpharmacological therapies and nonopioid medications or devices used to treat pain.</title>
    <title type="short" as="reported to house">Medicare CHOICE Act of 2018</title>
    <title type="short" as="reported to house">Medicare CHOICE Act of 2018</title>
    <title type="short" as="reported to house">Medicare Clear Health Options in Care for Enrollees Act of 2018</title>
    <title type="short" as="reported to house">Medicare Clear Health Options in Care for Enrollees Act of 2018</title>
    <title type="short" as="introduced">Medicare CHOICE Act of 2018</title>
    <title type="short" as="introduced">Medicare CHOICE Act of 2018</title>
    <title type="short" as="introduced">Medicare Clear Health Options in Care for Enrollees Act of 2018</title>
    <title type="short" as="introduced">Medicare Clear Health Options in Care for Enrollees Act of 2018</title>
    <title type="display">Medicare Clear Health Options in Care for Enrollees Act of 2018</title>
  </titles>
  <sponsor bioguide_id="P000594"/>
  <cosponsors>
    <cosponsor bioguide_id="B001243" joined="2018-05-09"/>
    <cosponsor bioguide_id="C001092" joined="2018-05-07"/>
    <cosponsor bioguide_id="F000466" joined="2018-05-21"/>
    <cosponsor bioguide_id="K000188" joined="2018-05-07"/>
    <cosponsor bioguide_id="L000588" joined="2018-05-07"/>
    <cosponsor bioguide_id="W000791" joined="2018-05-23"/>
  </cosponsors>
  <actions>
    <action datetime="2018-05-07">
      <text>Introduced in House</text>
    </action>
    <action datetime="2018-05-07" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2018-05-07">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2018-05-09">
      <text>Committee Consideration and Mark-up Session Held.</text>
    </action>
    <calendar datetime="2018-05-09" state="REPORTED">
      <text>Ordered to be Reported by Voice Vote.</text>
    </calendar>
    <action datetime="2018-05-16">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2018-06-12">
      <text>Reported by the Committee on Energy and Commerce. H. Rept. 115-741, Part I.</text>
    </action>
    <action datetime="2018-06-12">
      <text>Committee on Ways and Means discharged.</text>
    </action>
    <calendar datetime="2018-06-12" calendar="Union" number="575">
      <text>Placed on the Union Calendar, Calendar No. 575.</text>
    </calendar>
  </actions>
  <committees>
    <committee subcommittee="" code="HSWM" name="House Ways and Means" activity="Discharged, Referral"/>
    <committee subcommittee="Health" code="HSWM02" name="House Ways and Means" activity="Referral"/>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Reporting, Markup, Referral"/>
  </committees>
  <relatedbills>
    <bill type="h" session="115" relation="unknown" number="5775"/>
    <bill type="h" session="115" relation="unknown" number="6"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Alternative treatments"/>
    <term name="Drug trafficking and controlled substances"/>
    <term name="Health care costs and insurance"/>
    <term name="Medicare"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2018-06-12T15:00:03Z" status="Reported to House without amendment, Part I">Medicare Clear Health Options in Care for Enrollees Act of 2018 or the Medicare CHOICE Act of 2018

This bill requires Medicare and Medicare Advantage prescription drug plan (PDP) sponsors to annually disclose information to enrollees about: (1) the adverse effects of prolonged opioid use; and (2) the plan's coverage of nonpharmacological therapies, devices, and non-opioid medications. PDP sponsors may limit disclosure to a subset of enrollees (such as those who were prescribed an opioid in the previous two-year period).</summary>
  <committee-reports>
    <report>H. Rept. 115-741</report>
  </committee-reports>
</bill>
